Giulio Perugi Selected Research

Cyclothymic Disorder

9/2015	Cyclothymia reloaded: A reappraisal of the most misconceived affective disorder.
2/2008	Cocaine abuse and the bipolar spectrum in 1090 heroin addicts: clinical observations and a proposed pathophysiologic model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giulio Perugi Research Topics

Disease

33	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 12/2002
18	Mania (Manias) 01/2020 - 12/2002
15	Substance-Related Disorders (Drug Abuse) 12/2020 - 08/2004
14	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2022 - 05/2010
13	Anxiety Disorders (Anxiety Disorder) 05/2021 - 01/2002
9	Mental Disorders (Mental Disorder) 01/2021 - 06/2004
8	Panic Disorder (Panic Attack) 04/2022 - 01/2002
8	Major Depressive Disorder (Major Depressive Disorders) 01/2019 - 04/2005
5	Mood Disorders (Mood Disorder) 01/2022 - 02/2010
5	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 05/2015 - 08/2004
4	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 08/2006
4	Catatonia 09/2021 - 06/2015
4	Heroin Dependence (Heroin Abuse) 01/2018 - 02/2008
4	Psychomotor Agitation (Akathisia) 01/2017 - 04/2005
4	Depressive Disorder (Melancholia) 01/2017 - 04/2005
4	Agoraphobia 10/2010 - 01/2002
3	Feeding and Eating Disorders (Eating Disorder) 04/2022 - 01/2017
3	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2021 - 03/2015
3	Alcoholism (Alcohol Abuse) 01/2017 - 12/2002
3	Opioid-Related Disorders (Opiate Addiction) 07/2007 - 08/2006
2	Dementia (Dementias) 07/2022 - 03/2019
2	Psychotic Disorders (Schizoaffective Disorder) 01/2018 - 02/2008
2	Social Phobia 01/2018 - 08/2004
2	Medically Unexplained Symptoms 01/2018 - 01/2011
2	Obesity 01/2017 - 02/2014
2	Cyclothymic Disorder 09/2015 - 02/2008
2	Conduct Disorder (Conduct Disorders) 05/2010 - 08/2006
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Catalepsy 09/2021
1	Disease Progression 01/2021
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2021
1	Neurodevelopmental Disorders 08/2019
1	Disease Susceptibility (Diathesis) 01/2019
1	Gambling (Pathological Gambling) 01/2018
1	Thyroid Diseases (Thyroid Disease) 10/2017
1	Neuroleptic Malignant Syndrome 06/2015
1	Fatigue 03/2015
1	Neurobehavioral Manifestations 03/2015
1	Encephalitis (Encephalitis, Rasmussen) 01/2015
1	Turner Syndrome (Turner's Syndrome) 01/2015
1	Parkinson Disease (Parkinson's Disease) 11/2012
1	Hallucinations (Hallucination) 11/2012
1	Weight Loss (Weight Reduction) 09/2011
1	Schizophrenia (Dementia Praecox) 04/2011

Drug/Important Bio-Agent (IBA)

22	Antidepressive Agents (Antidepressants)IBA 05/2021 - 12/2002
13	Heroin (Diamorphine)IBA 10/2021 - 08/2006
12	3,4-methylenedioxyethamphetamine (MDEA)IBA 01/2021 - 04/2005
8	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 01/2010
7	Cocaine (Cocaine HCl)IBA 01/2022 - 08/2006
7	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 05/2015 - 01/2002
6	LithiumIBA 01/2021 - 05/2010
6	Pharmaceutical PreparationsIBA 01/2018 - 09/2011
6	Methadone (Dolophine)FDA LinkGeneric 01/2018 - 01/2005
5	Valproic Acid (Depakote)FDA LinkGeneric 10/2012 - 06/2004
4	Opioid Analgesics (Opioids)IBA 10/2021 - 01/2007
4	Hypnotics and Sedatives (Sedatives)IBA 01/2018 - 12/2002
4	Anticonvulsants (Antiepileptic Drugs)IBA 10/2014 - 06/2004
3	Caffeine (No Doz)FDA LinkGeneric 01/2022 - 01/2018
3	CannabinoidsIBA 01/2022 - 02/2010
3	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 10/2019 - 01/2015
3	BenzodiazepinesIBA 12/2015 - 01/2002
3	Duloxetine Hydrochloride (Cymbalta)FDA Link 12/2011 - 01/2011
3	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2011 - 01/2002
3	Serotonin (5 Hydroxytryptamine)IBA 01/2011 - 01/2002
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
2	Dopamine Agonists (Dopamine Agonist)IBA 09/2021 - 11/2012
2	Methylphenidate (Ritalin)FDA LinkGeneric 10/2019 - 01/2017
2	Nicotine FDA Link 01/2018 - 12/2002
2	AmphetaminesIBA 01/2017 - 02/2010
2	Aripiprazole (Abilify)FDA Link 10/2012 - 01/2010
2	Coffee FDA Link 09/2011 - 12/2002
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2011 - 01/2002
2	Topiramate (Topamax)FDA LinkGeneric 03/2010 - 06/2004
2	Gabapentin (Neurontin)FDA LinkGeneric 06/2004 - 12/2002
1	SynucleinsIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Cholinergic Antagonists (Anticholinergics)IBA 09/2021
1	N 30IBA 01/2021
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2021
1	CreatinineIBA 01/2021
1	2,5-dichloro-4-bromophenol (B 2)IBA 11/2020
1	Dronabinol (THC)FDA LinkGeneric 01/2020
1	Complement System Proteins (Complement)IBA 03/2019
1	Lithium Carbonate (Eskalith)FDA LinkGeneric 12/2017
1	AutoantibodiesIBA 10/2017
1	Modafinil (Provigil)FDA Link 01/2017
1	AMPA Receptors (AMPA Receptor)IBA 01/2015
1	asenapine FDA Link 08/2014
1	Retinaldehyde (Retinal)IBA 12/2011
1	Zonisamide (Zonegran)FDA LinkGeneric 09/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	InterleukinsIBA 01/2011
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2011

Therapy/Procedure

8	Drug Therapy (Chemotherapy) 07/2022 - 01/2009
7	Therapeutics 09/2021 - 06/2004
2	Bariatric Surgery 04/2022 - 01/2021
2	Self Medication 10/2019 - 04/2011
1	Combined Modality Therapy 11/2020
1	Precision Medicine 01/2019